HONG KONG, April 15 (Reuters) - Biotech company Hutchison China MediTech, known as Chi-Med, has filed for a Hong Kong listing, which four sources close to the matter said could raise up to $500 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results